Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
As the pharma industry is challenged with managing more data from more sources, more products, and increasing regulatory and reporting requirements, PV teams are looking towards automation and artificial intelligence to improve efficiency within their drug safety process. Once aspirational, these tools are now a ‘must have’ in order to maintain compliance. NLP, which can be used to understand context and intricacies of natural language throughout massive data sets, can be leveraged to automatically detect, extract, and intake unstructured and structured data from internal and external sources, including social media and mobile apps.
This webinar will show how NLP can be applied in the pharmacovigilance process, focusing on upstream detection of potential adverse events, and other risks and converting them to cases as necessary.
The presentation will:
Learn how to drive PV transformation with automation. Register for our webinar today.
Practice Leader, Technology Solutions
IQVIA
As Practice Leader for the Technology Solutions business unit of IQVIA, Updesh Dosanjh is responsible developing the overarching strategy regarding Artificial Intelligence and Machine Learning as it relates to safety and pharmacovigilance. He is focused on the adoption of these innovative technologies and processes that will help optimize pharmacovigilance activities for better, faster results. Dosanjh has over 25 years of knowledge and experience in the management, development, implementation, and operation of processes and systems within the life sciences and other industries. Most recently, Dosanjh was with Foresight and joined IQVIA as a result of an acquisition.
Over the course of his career, Dosanjh also worked with WCI, Logistics Consulting Partners, Amersys Systems Limited, and FJ Systems. Dosanjh holds a Bachelor’s degree in Materials Science from Manchester University and a Master’s degree in Advanced Manufacturing Systems and Technology from Liverpool University.
Senior Director and General Manager, Technology Solutions
IQVIA
As General Manager of Detect (powered by AETracker®), Alison’s focus is on driving the vision to provide customers with a tech-enabled optimized approach to adverse event and risk detection in structured and unstructured data. Alison joined Quintiles Drug Safety over 20 years ago. Shortly thereafter, she assumed a customer managed secondment to a pharmaceutical company for 15 months in the UK. During this time, Alison gained experience in a wide range of pharmacovigilance tasks from clinical trials to post marketing and on return to Quintiles she expanded her roles in clinical trials, endpoint management, regulatory reporting and line management. Alison’s leadership roles included European leadership of the Pharmacovigilance unit (all functions), global leadership of the Clinical Endpoint Validation and Adjudication (CEVA) Department and subsequently global
leadership of the Regulatory Reporting Department, including growing the teams, building out processes, and directing the operational, contractual, financial and customer facing aspects of the organization.
Alison graduated from Trinity College, Dublin, Ireland, with an Honors degree in Natural Science and an MSc and a Diploma in Statistics. Since 2016, Alison’s roles have been focused on PV automation and innovation, leveraging her 20+ years of safety experience.
Maire Gerrard
Custom Content Writer
Informa Pharma Intelligence